Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intensity-Modulated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00814567
What this trial is testing

Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 2,018
Large-scale testing (Phase 3)UnknownNCT02526953
What this trial is testing

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

Who this might be right for
Anus NeoplasmsCarcinoma, Squamous CellAnus Diseases+3 more
Blokhin's Russian Cancer Research Center 314
Testing effectiveness (Phase 2)Study completedNCT01266512
What this trial is testing

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer

Who this might be right for
Lung Neoplasms
Sanofi 34
Not applicableUnknownNCT03981068
What this trial is testing

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Who this might be right for
Head and Neck Neoplasms
Danish Head and Neck Cancer Group 20
Not applicableUnknownNCT06136962
What this trial is testing

Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01166191
What this trial is testing

Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC)

Who this might be right for
Stage I-III Small Cell Lung Cancer
Maastricht Radiation Oncology 60
Testing effectiveness (Phase 2)UnknownNCT00938418
What this trial is testing

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage III Non-Small Cell Lung Cancer
National University Hospital, Singapore 43
Early research (Phase 1)Ended earlyNCT03696537
What this trial is testing

IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more
Naoyuki G. Saito, M.D., Ph.D. 6
Early research (Phase 1)Ended earlyNCT06056310
What this trial is testing

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Who this might be right for
Head and Neck Cancer
EMD Serono Research & Development Institute, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT02663440
What this trial is testing

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)WithdrawnNCT02678520
What this trial is testing

Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients

Who this might be right for
Prostate Cancer
University of Kansas Medical Center
Testing effectiveness (Phase 2)UnknownNCT01595061
What this trial is testing

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

Who this might be right for
Stage III Vulvar Cancer AJCC v7Stage IIIA Vulvar Cancer AJCC v7Stage IIIB Vulvar Cancer AJCC v7+3 more
Gynecologic Oncology Group 57
Early research (Phase 1)Looking for participantsNCT06611150
What this trial is testing

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 24
Testing effectiveness (Phase 2)Temporarily pausedNCT03164460
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Head and Neck Carcinoma
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Looking for participantsNCT06939582
What this trial is testing

Hydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis

Who this might be right for
Radiation-induced Oral Mucositis
Xingchen Peng 158
Testing effectiveness (Phase 2)Study completedNCT03839602
What this trial is testing

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

Who this might be right for
Target Volume DelineationEarly-stage Nasopharyngeal CarcinomaIntensity Modulated Radiation Therapy
Sun Yat-sen University 103
Testing effectiveness (Phase 2)Study completedNCT01005329
What this trial is testing

Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+9 more
National Cancer Institute (NCI) 34
Not applicableUnknownNCT04101656
What this trial is testing

Accelerated Partial Irradiation of the Breast: New Altered Fractionation

Who this might be right for
Breast Cancer
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 174
Testing effectiveness (Phase 2)UnknownNCT03666221
What this trial is testing

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital 67
Not applicableStudy completedNCT00193804
What this trial is testing

A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix

Who this might be right for
Cancer of Cervix
Tata Memorial Hospital 200
Next Page